Hepatitis B virus core particles as a vaccine carrier moiety (Q40391210)

20 September 2017

1 reference

title

Hepatitis B virus core particles as a vaccine carrier moiety (English)

1 reference

20 September 2017

1 reference

Schödel F

1

1 reference

20 September 2017

Peterson D

series ordinal

2

1 reference

20 September 2017

Hughes J

series ordinal

3

1 reference

20 September 2017

Milich D

series ordinal

4

1 reference

20 September 2017

publication date

1 January 1994

1 reference

International Reviews of Immunology

20 September 2017

published in

1 reference

20 September 2017

volume

11

1 reference

20 September 2017

issue

2

1 reference

20 September 2017

page(s)

153-165

1 reference

Hepatitis B virus gene function: the precore region targets the core antigen to cellular membranes and causes the secretion of the e antigen

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08830189409061723

Expression of hepatitis B viral core region in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189409061723

Expression mechanism of the hepatitis B virus (HBV) C gene and biosynthesis of HBe antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189409061723

A signal peptide encoded within the precore region of hepatitis B virus directs the secretion of a heterogeneous population of e antigens in Xenopus oocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189409061723

The reverse transcriptase of hepatitis B virus acts as a protein primer for viral DNA synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189409061723

Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189409061723

A new hepatitis B virus strain in patients with severe anti-HBe positive chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189409061723

A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189409061723

Posttransfusion fulminant hepatitis B associated with precore-defective HBV mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189409061723

Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189409061723

The serology of chronic hepatitis B infection revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189409061723

Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189409061723

Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189409061723

The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189409061723

Induction of anti-human immunodeficiency virus (HIV) neutralizing antibodies in rabbits immunized with recombinant HIV--hepatitis B surface antigen particles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189409061723

Epitopes of the human malaria parasite P. falciparum carried on the surface of HBsAg particles elicit an immune response against the parasite

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189409061723

Protective immunisation against hepatitis B with an internal antigen of the virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189409061723

Immunization with recombinant woodchuck hepatitis virus nucleocapsid antigen or hepatitis B virus nucleocapsid antigen protects woodchucks from woodchuck hepatitis virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189409061723

Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189409061723

Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189409061723

Immunogenicity of peptide fusions to hepatitis B virus core antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189409061723

Recombinant core particles of hepatitis B virus exposing foreign antigenic determinants on their surface

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189409061723

Presentation and Immunogenicity of Viral Epitopes on the Surface of Hybrid Hepatitis B Virus Core Particles Produced in Bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189409061723

Immunological properties of hepatitis B core antigen fusion proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189409061723

Foreign epitopes in immunodominant regions of hepatitis B core particles are highly immunogenic and conformationally restricted

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189409061723

Expression in yeast of amino-terminal peptide fusions to hepatitis B core antigen and their immunological properties

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189409061723

Immunogenicity of recombinant core particles of hepatitis B virus containing epitopes of human immunodeficiency virus 1 core antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189409061723

Efficient oligonucleotide-directed construction of mutations in expression vectors by the gapped duplex DNA method using alternating selectable markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189409061723

Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189409061723

T- and B-cell recognition of hepatitis B viral antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189409061723

10.3109/08830189409061723

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference